Primary active transport of organic anions on bile canalicular membrane in humans

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 5 39-5, 1999, Pages

  Niinuma, Kayoko ^a   Kato, Yukio ^a   Suzuki, Hiroshi ^a   Tyson, Charles A ^b   Weizer, Valorie ^b   Dabbs, Jack E ^b   Froehlich, Ritchie ^b   Green, Carol E ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SRI INTERNATIONAL   (United States)

Author keywords

Canalicular membrane vesicles; Canalicular multispecific organic anion transporter; Glucuronides; Glutathione conjugates; Species difference

Indexed keywords

2,4 DINITROPHENOL; 6 HYDROXY 5,7 DIMETHYL 2 METHYLAMINO 4 (3 PYRIDYLMETHYL)BENZOTHIAZOLE; ACIVICIN; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ANION; BROMSULFOPHTHALEIN; CARRIER PROTEIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYTOSOL AMINOPEPTIDASE; ESTRADIOL 17 GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; GLUCURONIDE; GLUTATHIONE DERIVATIVE; GREPAFLOXACIN; LEUKOTRIENE C4; METHOTREXATE; ORGANIC COMPOUND; PRAVASTATIN; TAUROCHOLIC ACID; XENOBIOTIC AGENT;

ACTIVE TRANSPORT; ADULT; ANIMAL CELL; ANIMAL TISSUE; ANION TRANSPORT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG ELIMINATION; DRUG EXCRETION; DRUG TRANSPORT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAHEPATIC BILE DUCT; MALE; MEMBRANE TRANSPORT; MEMBRANE VESICLE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT; XENOBIOTIC METABOLISM;

EID: 0032974409     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.5.g1153     Document Type: Article

References (55)

1. Anderson, M. P., R. J. Gregory, S. Thompson, D. W. Souza, S. Paul, R. C. Mulligan, A. E. Smith, and M. J. Welsh. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253: 202-205, 1991.
2. Barouki, R., M. Chobert, J. Finidori, M. Aggerbeck, B. Nalpas, and J. Hanoune. Ethanol effects in a rat hepatoma cell line: induction of γ-glutamyltransferase. Hepatology 3: 323-329, 1983.
3. Bissig, M., B. Hagenbuch, B. Stieger, T. Koller, and P. J. Meier. Functional expression cloning of the canalicular sulfate transport system of rat hepatocytes. J. Biol. Chem. 269: 3017-3021, 1994.
4. Bohme, M., M. Muller., I. Leier., G. Jedlitschky., and D. Keppler. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107: 255-265, 1994.
5. Bradford, M. M. A rapid and sensitive method for the quantitation of microsomal quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
6. Buchler, M., J. Konig, M. Brom, J. Kartenbeck, H. Spring, T. Horie, and D. Keppler. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem. 271: 15091-15098, 1996.
7. +-nucreoside cotransporter. J. Biol. Chem. 270: 13596-13599, 1995.
8. Chu, X., Y. Kato, K. Niinuma, K. Sudo, H. Hakusui, and Y. Sugiyama. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J. Pharmacol. Exp. Ther. 281: 304-314, 1997.
9. Chu, X., Y. Kato, and Y. Sugiyama. Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats. Cancer Res. 57: 1934-1938, 1997.
10. Chu, X., Y. Kato, K. Ueda, H. Suzuki, K. Niinuma, C. A. Tyson, V. Weizer, J. E. Dabbs, R. Froehlich, C. E. Green, and Y. Sugiyama. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters. Cancer Res. 58: 5137-5143, 1998.
11. Cole, S. P., G. Bhardwaj, J. H. Gerlach, J. E. Mackie, C. E. Grant, K. C. Almquist, A. J. Stewart, E. U. Kurz, A. M. Duncan, and B. G. Deeley. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
12. Elferink, R. P. J. O., D. K. F. Meijer, F. Kuipers, P. L. M. Jansen, A. K. Groen, and G. M. M. Groothuis. Hepatobiliary secretion of organic compounds; molecular mechanism of membrane transport. Biochim. Biophys. Acta 1241: 215-268, 1995.
13. Fernandez-Checa, J. C., H. Takikawa, T. Horie, M. Ookhtens, and N. Kaplowitz. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J. Biol. Chem. 267: 1667-1673, 1992.
14. Goldberg, D. M. Structual, functional, and clinical aspects of γ-glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 12: 1-58, 1980.
15. Hirohashi, T., H. Suzuki, K. Ito, K. Ogawa, K. Kume, T. Shimizu, and Y. Sugiyama. Hepatic expression of multidrug resistance-associated protein (MRP)-like proteins maintained in Eisai hyperbilirubinemic rats (EHBR). Mol. Pharmacol. 53: 1068-1075, 1998.
16. Ishikawa, T., M. Muller, C. Klunemann, T. Schaub, and D. Keppler. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. J. Biol. Chem. 265: 19279-19286, 1990.
17. Ishizuka, H., K. Konno, H. Naganuma, K. Sasahara, Y. Kawahara, K. Niinuma, H. Suzuki, and Y. Sugiyama. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). J. Pharmacol. Exp. Ther. 280: 1304-1311, 1997.
18. Ito, K., H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G16-G22, 1997.
19. Ito, K., H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama. Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J. Biol. Chem. 273: 1684-1688, 1998.
20. Iwatsubo, T., N. Hirota, T. Ooie, H. Suzuki, N. Shimada, K. Chiba, T. Ishizaki, C. E. Green, C. A. Tyson, and Y. Sugiyama. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol. Ther. 73: 147-171, 1997.
21. Iwatsubo, T., N. Hirota, T. Ooie, H. Suzuki, and Y. Sugiyama. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics. Biopharm. Drug Dispos. 17: 273-310, 1996.
22. Jansen, P. L. M., W. H. M. Peters, and W. H. Lamers. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 5: 573-579, 1985.
23. Jedlitschky, G., I. Leier, U. Buchholz, M. Center, and D. Keppler. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance associated protein. Cancer Res. 54: 4833-4836, 1994.
24. Kanno, T., M. Maekawa, S. Kanda, H. Kohno, and K. Sudo. Evaluation of cytosolic aminopeptidase in human sera, evaluation in hepatic disorders. Am. J. Clin. Pathol. 82: 700-705, 1984.
25. Kobayashi, K., Y. Sogame, H. Hara, and K. Hayashi. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J. Biol. Chem. 265: 7737-7741, 1990.
26. Kool, M., M. de Haas, G. L. Scheffer, R. J. Scheper, M. J. van Eijk, J. A. Juijn, F. Baas, and P. Borst. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57: 3537-3547, 1997.
27. Leier, I., G. Jedlitschky, U. Buchholz, M. Center, S. P. Cole, R. G. Deeley, and D. Keppler. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 314: 433-437, 1996.
28. Lokiec, F., P. Canal, C. Gay, E. Chatelut, J. P. Armand, H. Roche, R. Bugat, E. Goncalves, and B. A. Mathincu. Pharmacokinetics of irinotecan and its metabolites in human blood, bile, and urine. Cancer Chemother. Pharmacol. 36: 79-82, 1995.
29. Madon, J., U. Eckhardt, T. Gerloff, B. Stieger, and P. J. Meier. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett. 406: 75-78, 1997.
30. Mayer, R., J. Kartenbeck, M. Buchler, G. Jedlitschky, I. Leier, and D. Keppler. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 131: 137-150, 1995.
31. Mikami, T., T. Nozaki, O. Tagaya, S. Hosokawa, T. Nakura, H. Mori, and S. Kondou. The characters of a new mutant in rats with hyperbilirubinuria syndrome. Cong. Anom. 26: 250-251, 1986.
32. + exchanger. J. Pharmacol. Exp. Ther. 281: 34-40, 1997.
33. Muller, M., C. Meijer, G. J. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. G. de Vries, and P. L. Jansen. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91: 13033-13037, 1994.
34. Muller, M., H. Roelofsen, and P. L. Jansen. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein. Semin. Liver Dis. 16: 211-219, 1996.
35. Nakamura, T., A. Hisaka, Y. Sasaki, Y. Suzuki, K. Ishikawa, M. Yano, and Y. Sugiyama. Carrier mediated active transport of BQ-123 a peptidic endothelin antagonist, into rat hepatocytes. J. Pharmacol. Exp. Ther. 278: 564-572, 1996.
36. Niinuma, K., O. Takenaka, T. Horie, K. Kobayashi, Y. Kato, H. Suzuki, and Y. Sugiyama. Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide. J. Pharmacol. Exp. Ther. 282: 866-872, 1997.
37. - rat liver canalicular membranes. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G629-G635, 1992.
38. 1B receptors. Nature 360: 161-163, 1992.
39. Patterson, E. K., S. Hsiao, and A. Keppel. Studies on dipeptidases and aminopeptidases. I. Distinction between leucine aminopeptidase and enzymes that hydrolyze L-leucyl-β-naphthylamide. J. Biol. Chem. 238: 3611-3620, 1963.
40. Paulusma, C. C., P. J. Bosma, G. J. R. Zaman, C. T. M. Bakker, M. Otter, G. L. Scheffer, R. S. J. Scheper, P. Borst, and P. J. Oude Elferink. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128, 1996.
41. Sasabe, H., A. Tsuji, and Y. Sugiyama. Carrier-mediated mechanism for the biliary excretion of a quinolone antibiotic, grepafloxacin and its glucuronide in rats. J. Pharmacol. Exp. Ther. 284: 1033-1039, 1998.
42. Saxena, M., and G. B. Henderson. ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. J. Biol. Chem. 270: 5312-5319, 1995.
43. Shin, H., Y. Kato, T. Yamada, K. Niinuma, A. Hisaka, and Y. Sugiyama. Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G979-G986, 1997.
44. Takahashi, H., R. B. Kim, P. R. Perry, and G. R. Wilkinson. Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren. J. Pharmacol. Exp. Ther. 281: 297-303, 1997.
45. Takenaka, O., T. Horie, H. Suzuki, K. Kobayashi, and Y. Sugiyama. Kinetic analysis of hepatobiliary transport for conjugative metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugative hyperbilirubinemia. Pharm. Res. 12: 1746-1755, 1995.
46. Takikawa, H., N. Sano, T. Narita, Y. Uchida, M. Yamanaka, T. Horie, T. Mikami, and O. Tagaya. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 14: 352-360, 1991.
47. Takikawa, H., R. Yamazaki, N. Sano, and M. Yamanaka. Biliary excretion of estradiol-17-glucuronide in the rat. Hepatology 23: 607-613, 1996.
48. Taniguchi, K., M. Wada, K. Kohno, T. Nakamura, T. Kawabe, M. Kawakami, K. Kagotani, K. Okumura, S. Akiyama, and M. Kuwano. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56: 4124-4129, 1996.
49. Wolters, H., F. Kuipers, M. J. H. Slooff, and R. J. Vonk. Adenosine triphosphate-dependent taurocholate transport in human liver plasma membranes. J. Clin. Invest. 90: 2321-2326, 1992.
50. Wolters, H., M. Spiering, A. Gerding, M. J. H. Slooff, F. Kuipers, M. J. Hardonk, and R. J. Vonk. Isolation and characterization of canalicular and basolateral plasma mem brane fractions from human liver. Biochim. Biophys. Acta 1069: 61-69, 1991.
51. Yachi, K., Y. Sugiyama, Y. Sawada, T. Iga, Y. Ikeda, G. Toda, and M. Hanano. Characterization of rose bengal binding to sinusoidal and canalicular plasma membrane from rat liver. Biochim. Biophys. Acta 978: 1-7, 1989.
52. Yamaoka, K., Y. Tanigawara, Y. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4: 879-885, 1981.
53. Yamazaki, M., K. Kobayashi, and Y. Sugiyama. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Biopharm. Drug Dispos. 17: 607-621, 1996.
54. Yamazaki, M., H. Suzuki, and Y. Sugiyama. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm. Res. 13: 497-513, 1996.
55. Ziegler, K., C. Kolac, and W. Ising. ATP-dependent transport of the linear renin-inhibiting peptide EMD-51921 by canalicular plasma membrane vesicles of rat liver: evidence of drug-stimulatable ATP-hydrolysis. Biochim. Biophys. Acta 1196: 209-217, 1994.